Dabur India Ltd
Dabur India is one of the leading fast moving consumer goods (FMCG) players dealing in consumer care and food products.(Source : 202003 Annual Report Page No:280)
- Market Cap ₹ 90,299 Cr.
- Current Price ₹ 510
- High / Low ₹ 672 / 489
- Stock P/E 62.4
- Book Value ₹ 40.8
- Dividend Yield 1.08 %
- ROCE 28.1 %
- ROE 22.9 %
- Face Value ₹ 1.00
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 23.6%
- Company has been maintaining a healthy dividend payout of 65.3%
Cons
- Stock is trading at 12.5 times its book value
- The company has delivered a poor sales growth of 7.81% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Personal Care - Indian
Part of BSE Dollex 200 Nifty Next 50 Nifty 500 BSE LargeCap Nifty 200
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4,342 | 4,860 | 5,420 | 5,340 | 5,291 | 5,592 | 6,273 | 6,310 | 7,185 | 8,180 | 8,684 | 9,136 | 9,112 | |
3,619 | 4,034 | 4,480 | 4,242 | 4,178 | 4,360 | 4,906 | 4,927 | 5,626 | 6,445 | 6,984 | 7,295 | 7,343 | |
Operating Profit | 723 | 826 | 940 | 1,098 | 1,112 | 1,232 | 1,367 | 1,383 | 1,559 | 1,734 | 1,701 | 1,840 | 1,768 |
OPM % | 17% | 17% | 17% | 21% | 21% | 22% | 22% | 22% | 22% | 21% | 20% | 20% | 19% |
94 | 108 | 112 | 194 | 274 | 266 | 275 | 175 | 277 | 341 | 363 | 416 | 444 | |
Interest | 18 | 19 | 10 | 10 | 16 | 22 | 30 | 19 | 9 | 19 | 46 | 81 | 96 |
Depreciation | 49 | 54 | 66 | 73 | 75 | 102 | 109 | 130 | 143 | 160 | 188 | 209 | 230 |
Profit before tax | 750 | 861 | 977 | 1,209 | 1,294 | 1,373 | 1,503 | 1,408 | 1,683 | 1,896 | 1,829 | 1,967 | 1,886 |
Tax % | 21% | 22% | 22% | 22% | 23% | 22% | 16% | 17% | 18% | 24% | 25% | 23% | |
591 | 672 | 763 | 937 | 998 | 1,072 | 1,264 | 1,170 | 1,382 | 1,433 | 1,373 | 1,509 | 1,446 | |
EPS in Rs | 3.39 | 3.85 | 4.34 | 5.33 | 5.67 | 6.09 | 7.16 | 6.62 | 7.82 | 8.11 | 7.75 | 8.52 | 8.17 |
Dividend Payout % | 44% | 45% | 46% | 42% | 40% | 123% | 38% | 45% | 61% | 64% | 67% | 65% |
Compounded Sales Growth | |
---|---|
10 Years: | 7% |
5 Years: | 8% |
3 Years: | 8% |
TTM: | 2% |
Compounded Profit Growth | |
---|---|
10 Years: | 9% |
5 Years: | 4% |
3 Years: | 3% |
TTM: | 0% |
Stock Price CAGR | |
---|---|
10 Years: | 8% |
5 Years: | 2% |
3 Years: | -3% |
1 Year: | -4% |
Return on Equity | |
---|---|
10 Years: | 27% |
5 Years: | 25% |
3 Years: | 24% |
Last Year: | 23% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 174 | 174 | 176 | 176 | 176 | 176 | 177 | 177 | 177 | 177 | 177 | 177 | 177 |
Reserves | 1,391 | 1,728 | 2,161 | 2,918 | 3,482 | 4,051 | 3,792 | 4,398 | 5,214 | 5,687 | 6,110 | 6,738 | 7,048 |
242 | 44 | 129 | 87 | 284 | 287 | 310 | 151 | 180 | 560 | 615 | 776 | 1,194 | |
991 | 1,175 | 1,223 | 1,248 | 1,275 | 1,299 | 1,300 | 1,375 | 1,933 | 2,168 | 2,450 | 2,841 | 3,001 | |
Total Liabilities | 2,798 | 3,122 | 3,688 | 4,430 | 5,217 | 5,813 | 5,579 | 6,100 | 7,504 | 8,592 | 9,352 | 10,533 | 11,421 |
617 | 654 | 683 | 639 | 993 | 1,030 | 1,037 | 1,134 | 1,205 | 1,399 | 1,662 | 1,878 | 2,019 | |
CWIP | 17 | 17 | 12 | 25 | 28 | 27 | 22 | 106 | 107 | 128 | 109 | 184 | 58 |
Investments | 1,026 | 1,118 | 1,778 | 2,570 | 3,054 | 3,433 | 2,962 | 2,467 | 3,574 | 5,007 | 5,475 | 6,148 | 6,709 |
1,139 | 1,333 | 1,215 | 1,196 | 1,141 | 1,322 | 1,558 | 2,393 | 2,618 | 2,057 | 2,106 | 2,322 | 2,635 | |
Total Assets | 2,798 | 3,122 | 3,688 | 4,430 | 5,217 | 5,813 | 5,579 | 6,100 | 7,504 | 8,592 | 9,352 | 10,533 | 11,421 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
703 | 712 | 839 | 960 | 927 | 816 | 1,124 | 1,155 | 1,704 | 1,320 | 1,562 | 1,653 | |
-346 | -98 | -613 | -494 | -679 | -261 | 418 | -330 | -1,120 | -682 | -617 | -736 | |
-328 | -535 | -337 | -455 | -274 | -496 | -1,619 | -826 | -555 | -635 | -940 | -922 | |
Net Cash Flow | 29 | 79 | -111 | 11 | -26 | 59 | -78 | -2 | 29 | 3 | 5 | -5 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 21 | 24 | 23 | 29 | 23 | 21 | 25 | 22 | 14 | 20 | 24 | 29 |
Inventory Days | 107 | 109 | 94 | 106 | 103 | 117 | 106 | 120 | 141 | 132 | 118 | 109 |
Days Payable | 123 | 137 | 130 | 160 | 157 | 159 | 145 | 153 | 187 | 169 | 176 | 195 |
Cash Conversion Cycle | 6 | -4 | -13 | -25 | -31 | -21 | -13 | -11 | -32 | -16 | -34 | -58 |
Working Capital Days | 0 | -5 | -4 | -1 | -7 | 1 | -8 | 0 | -17 | -10 | -16 | -23 |
ROCE % | 44% | 46% | 45% | 42% | 37% | 33% | 35% | 34% | 33% | 32% | 28% | 28% |
Documents
Announcements
-
Board Meeting Intimation for Considering Unaudited Financial Results For The Quarter And Nine Months Ending On 31.12.2024.
20 Dec - Board meeting to consider unaudited financial results.
- Closure of Trading Window 20 Dec
-
Submission Of Information Under Regulation 30 Of SEBI (LODR) Regulations, 2015
13 Dec - Disclosure of penalty paid to State Tax Officer.
-
Submission Of Information Under Regulation 30 Of SEBI (LODR) Regulations, 2015.
6 Dec - Dabur Tunisia dissolution completion extended to December 2025.
-
Submission Of Information Under Regulation 30 Of SEBI (LODR) Regulations, 2015.
6 Dec - Disclosure of customs tax demand order received.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from nse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
Nov 2024Transcript PPT
-
Oct 2024TranscriptNotesPPT
-
Aug 2024Transcript PPT
-
Aug 2024TranscriptNotesPPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Jan 2024TranscriptNotesPPT
-
Nov 2023Transcript PPT
-
Nov 2023TranscriptNotesPPT
-
Nov 2023TranscriptNotesPPT
-
Sep 2023TranscriptNotesPPT
-
Sep 2023TranscriptNotesPPT
-
Aug 2023TranscriptNotesPPT
-
Aug 2023Transcript PPT
-
Aug 2023TranscriptNotesPPT
-
May 2023Transcript PPT
-
May 2023TranscriptNotesPPT
-
Feb 2023Transcript PPT
-
Oct 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Aug 2022TranscriptNotesPPT
-
Jun 2022Transcript PPT
-
May 2022TranscriptNotesPPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Aug 2021TranscriptNotesPPT
-
May 2021Transcript PPT
-
May 2021TranscriptNotesPPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Sep 2020Transcript PPT
-
Jul 2020TranscriptNotesPPT
-
Jun 2020Transcript PPT
-
Feb 2020Transcript PPT
-
Nov 2019Transcript PPT
-
Nov 2019TranscriptNotesPPT
-
Sep 2019TranscriptNotesPPT
-
Aug 2019TranscriptNotesPPT
-
Jul 2019Transcript PPT
-
May 2019Transcript PPT
-
Feb 2019Transcript PPT
-
Nov 2018Transcript PPT
-
Aug 2018TranscriptNotesPPT
-
Aug 2018Transcript PPT
-
Jul 2018TranscriptNotesPPT
-
May 2018TranscriptNotesPPT
-
Feb 2018TranscriptNotesPPT
-
Jan 2018TranscriptNotesPPT
-
Nov 2017Transcript PPT
-
Sep 2017TranscriptNotesPPT
-
Aug 2017Transcript PPT
-
May 2017Transcript PPT
-
Feb 2017TranscriptPPT
-
Nov 2016TranscriptPPT
-
Jul 2016TranscriptNotesPPT
-
Jun 2016TranscriptNotesPPT
-
May 2016Transcript PPT
-
Feb 2016Transcript PPT
Leading FMCG Company Dabur India Limited is the fourth largest FMCG Company in India and the world’s largest Ayurvedic and Natural Health Care Company with a portfolio of over 250 Herbal/Ayurvedic products.[1]